Table 1.
Baseline patient characteristics
| Characteristics | Group | P value | Subgroup | P value | ||
|---|---|---|---|---|---|---|
| Control (n = 128) | Patient (n = 128) | Subgroup 1 (n = 30) | Subgroup 2 (n = 300) | |||
| Gender: | ||||||
| Men (%) | 64 (50%) | 64 (50%) | 1a | 17 (56.7%) | 17 (56.7%) | 1a |
| Women (%) | 64 (50%) | 64 (50%) | 1a | 13 (43.3%) | 13 (43.3%) | 1a |
| Mean ± SD. age (yr) | 43.3 ± 12.6 | 41.9 ± 14.7 | 0.43b | 36.0 ± 10.0 | 39.1 ± 14.5 | 0.34b |
| Mean ± SD. BMI | 21.9 ± 3.2 | 21.9 ± 3.1 | 0.93b | - | - | - |
| Mean ± SD. Disease duration (yr) | - | 7.7 ± 8.1 | - | 5.8 ± 5.4 | 5.6 ± 5.4 | 0.89b |
| Clinical features | ||||||
| Psoriasis vugaris | 100 (78.1%) | 30 (100%) | 30 (100%) | |||
| Erythrodermic psoriasis | - | 11 (8.6%) | - | 0 | 0 | 1a |
| Pustular psoriasis | 9 (7%) | 0 | 0 | |||
| Arthritis psoriasis | 8 (6.3%) | 0 | 0 | |||
| PASI score: mean ± SD | - | 10.9 ± 7.4 | - | 12.8 ± 5.8 | 11.8 ± 5.1 | 0.51b |
a
Chi-square test;
b
Two–tailed Student’s test.